Optimizing communication for ultrafast lung cancer biomarker testing: the UTOPIA pilot study
{{output}}
Background: Non-small cell lung carcinoma (NSCLC) is a leading example of precision oncology, with a growing number of actionable targets. However, long turnaround times (TAT) for biomarker results can delay optimal treatment dec... ...
